0001062993-23-023027.txt : 20231221
0001062993-23-023027.hdr.sgml : 20231221
20231221160433
ACCESSION NUMBER: 0001062993-23-023027
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231219
FILED AS OF DATE: 20231221
DATE AS OF CHANGE: 20231221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weber Kathleen Gallagher
CENTRAL INDEX KEY: 0001756089
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16537
FILM NUMBER: 231505291
MAIL ADDRESS:
STREET 1: 220 EAST FIRST STREET
CITY: BETHLEHEM
STATE: PA
ZIP: 18017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ORASURE TECHNOLOGIES INC
CENTRAL INDEX KEY: 0001116463
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 364370966
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 220 E FIRST ST
CITY: BETHLEHEM
STATE: PA
ZIP: 18015
BUSINESS PHONE: 5036416115
MAIL ADDRESS:
STREET 1: 220 E FIRST ST
CITY: BETHLEHEM
STATE: PA
ZIP: 18015
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-12-19
0001116463
ORASURE TECHNOLOGIES INC
OSUR
0001756089
Weber Kathleen Gallagher
C/O ORASURE TECHNOLOGIES, INC.
220 EAST FIRST STREET
BETHLEHEM
PA
18015
0
1
0
0
Chief Product Officer
1
Common Stock
2023-12-19
4
M
0
4129
5.7149
A
278829
D
Common Stock
2023-12-19
4
S
0
24129
8.0492
D
254700
D
Non-Qualified Stock Options
5.7149
2023-12-19
4
M
0
4129
0
D
2024-02-03
Common Stock
4129
0
D
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023.
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.095, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Non-qualified stock options granted on February 3, 2014, vesting 25% at the end of 12 months after the grant date and 75% ratably on a monthly basis over the next 36 months. Vesting shall cease upon voluntary termination of employment.
/s/ Michele Anthony, Attorney-In-Fact
2023-12-21